IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 102 filers reported holding IRADIMED CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,873,500 | -24.5% | 628,206 | -18.8% | 2.57% | -37.4% |
Q2 2023 | $36,936,152 | +21.3% | 773,694 | 0.0% | 4.11% | +30.2% |
Q1 2023 | $30,444,859 | +44.5% | 773,694 | +3.9% | 3.15% | +4.3% |
Q4 2022 | $21,076,163 | +2.4% | 745,004 | +8.8% | 3.02% | +8.1% |
Q3 2022 | $20,582,000 | -2.3% | 684,690 | +10.3% | 2.80% | -14.9% |
Q2 2022 | $21,069,000 | +9.3% | 620,765 | +44.3% | 3.29% | +32.1% |
Q1 2022 | $19,283,000 | -7.3% | 430,051 | -4.4% | 2.49% | +19.5% |
Q4 2021 | $20,796,000 | +37.4% | 450,030 | -0.1% | 2.08% | -11.7% |
Q3 2021 | $15,138,000 | +3.5% | 450,679 | -9.4% | 2.36% | +4.9% |
Q2 2021 | $14,622,000 | +17.7% | 497,179 | +3.1% | 2.25% | +0.5% |
Q1 2021 | $12,423,000 | +79.2% | 482,070 | +58.6% | 2.24% | +144.6% |
Q4 2020 | $6,931,000 | +63.1% | 303,998 | +53.0% | 0.92% | -59.4% |
Q3 2020 | $4,249,000 | -13.8% | 198,739 | -6.4% | 2.25% | -19.9% |
Q2 2020 | $4,930,000 | -1.7% | 212,436 | -9.5% | 2.81% | -51.8% |
Q1 2020 | $5,013,000 | +52.4% | 234,810 | +66.8% | 5.83% | +83.8% |
Q4 2019 | $3,290,000 | – | 140,752 | – | 3.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
RK Capital | 222,914 | $5,212,000 | 1.95% |
Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |